Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 686480, 4 pages
http://dx.doi.org/10.1155/2010/686480
Review Article

Efficacy and Cytokine Modulating Effects of Tacrolimus in Systemic Lupus Erythematosus: A Review

El Shaddai Arthritis and Rheumatism Specialist Medical Centre, Block 102, #01-258, Towner Road, Singapore 322102

Received 27 February 2010; Accepted 31 March 2010

Academic Editor: Brian Poole

Copyright © 2010 Kam Hon Yoon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [21 citations]

The following is the list of published articles that have cited the current article.

  • Undurti N Das, “Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation,” Journal of Inflammation Research, vol. 3, no. 1, pp. 143–170, 2010. View at Publisher · View at Google Scholar
  • Jaume Alijotas-Reig, Victor Garcia-Gimenez, and Miquel Vilardell-Tarrés, “Tacrolimus in the Treatment of Chronic and Refractory Late-Onset Immune-Mediated Adverse Effects Related to Silicone Injections,” Dermatologic Surgery, vol. 38, no. 1, pp. 38–47, 2011. View at Publisher · View at Google Scholar
  • K. Maeshima, K. Ishii, M. Torigoe, C. Imada, M. Iwakura, H. Hamasaki, M. Akamine, M. Haranaka, and H. Yoshimatsu, “Successful tocilizumab and tacrolimus treatment in a patient with rheumatoid arthritis complicated by systemic lupus erythematosus,” Lupus, vol. 21, no. 9, pp. 1003–1006, 2012. View at Publisher · View at Google Scholar
  • Kentaro Yomogida, Yuan Chou, Jonathan Pang, Bobby Baravati, Brian J. Maniaci, Shili Wu, Yong Zhu, and Cong-Qiu Chu, “Streptavidin suppresses T cell activation and inhibits IL-2 production and CD25 expression,” Cytokine, vol. 58, no. 3, pp. 431–436, 2012. View at Publisher · View at Google Scholar
  • T. Robak, and E. Robak, “Novel and Emerging Drugs for Systemic Lupus Erythematosus: Mechanism of Act ion and Therapeutic Activity,” Current Medicinal Chemistry, vol. 19, no. 3, pp. 438–453, 2012. View at Publisher · View at Google Scholar
  • Sachin Srinivasan, Sangmee Bae, Maureen McMahon, and Daniel E. Furst, “Drugs, trials and pathogenesis: Will Connecting these help us understand SLE?,” Current Rheumatology Reviews, vol. 9, no. 3, pp. 214–231, 2013. View at Publisher · View at Google Scholar
  • Mehmet Agirbasli, Emine Baş Bozkurtlar, Nurdan Papila-Topal, Hicran Deniz, Betul Ogutmen, and Fulya Cakalagaoglu, “Tacrolimus toxicity reverses the inhibitory effects of renin angiotensin system blockade on PAI-1 expression in cardiac tissue,” Current Enzyme Inhibition, vol. 9, no. 2, pp. 83–88, 2013. View at Publisher · View at Google Scholar
  • Ruyi Liao, Qinghua Liu, Zhihua Zheng, Jinjin Fan, Wenxing Peng, Qingyu Kong, Huijuan He, Shicong Yang, Wenfang Chen, Xueqing Tang, and Xueqing Yu, “Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis,” Plos One, vol. 10, no. 7, 2015. View at Publisher · View at Google Scholar
  • Chi Chiu Mok, and David Jayne, “Pro: The use of calcineurin inhibitors in the treatment of lupus nephritisOpponent's comments,” Nephrology Dialysis Transplantation, pp. gfw289, 2016. View at Publisher · View at Google Scholar
  • Rongsheng E. Wang, Ying Wang, Yuhan Zhang, Chase Gabrelow, Yong Zhang, Victor Chi, Qiangwei Fu, Xiaozhou Luo, Danling Wang, Sean Joseph, Kristen Johnson, Arnab K. Chatterjee, Timothy M. Wright, Vân T. B. Nguyen-Tran, John Teijaro, Argyrios N. Theofilopoulos, Peter G. Schultz, and Feng Wang, “Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant,” Proceedings of the National Academy of Sciences, pp. 201612803, 2016. View at Publisher · View at Google Scholar
  • Chi Chiu Mok, “Therapeutic monitoring of the immuno-modulating drugs in systemic lupus erythematosus,” Expert Review of Clinical Immunology, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Chi Chiu Mok, and Cees G.M. Kallenberg, “Con: Cyclophosphamide for the treatment of lupus nephritisOpponent's comments,” Nephrology Dialysis Transplantation, pp. gfw068, 2016. View at Publisher · View at Google Scholar
  • C. C. Mok, “Towards new avenues in the management of lupus glomerulonephritis,” Nature Reviews Rheumatology, 2016. View at Publisher · View at Google Scholar
  • Chi Chiu Mok, King Yee Ying, Cheuk Wan Yim, Yui Pong Siu, Ka Hang Tong, Chi Hung To, and Woon Leung Ng, “Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up,” Annals Of The Rheumatic Diseases, vol. 75, no. 1, pp. 30–36, 2016. View at Publisher · View at Google Scholar
  • Chi Chiu Mok, “Calcineurin inhibitors in systemic lupus erythematosus,” Best Practice and Research: Clinical Rheumatology, vol. 31, no. 3, pp. 429–438, 2017. View at Publisher · View at Google Scholar
  • Y Li, and X Feng, “Efficacy and safety of tacrolimus in systemic lupus erythematosus patients with refractory thrombocytopenia: a retrospective study,” Lupus, pp. 096120331771101, 2017. View at Publisher · View at Google Scholar
  • Jaume Alijotas-Reig, Enrique Esteve-Valverde, Natalia Gil-Aliberas, and Victor Garcia-Gimenez, “Autoimmune/inflammatory syndrome induced by adjuvants—ASIA—related to biomaterials: analysis of 45 cases and comprehensive review of the literature,” Immunologic Research, 2017. View at Publisher · View at Google Scholar
  • Maryam S. Sadati, Ladan Dastgheib, and Elham Aflaki, “Recalcitrant cases of Pyoderma gangrenosum, responding dramatically to systemic tacrolimus,” Giornale Italiano di Dermatologia e Venereologia, vol. 152, no. 3, pp. 308–310, 2017. View at Publisher · View at Google Scholar
  • Masashi Ohe, Haruki Shida, Tetsuya Horita, and Kenji Oku, “Successful treatment with clarithromycin and/or tacrolimus for two patients with polymyalgia rheumatica,” Drug Discoveries & Therapeutics, vol. 11, no. 4, pp. 223–225, 2017. View at Publisher · View at Google Scholar
  • D.-D. Wang, J.-M. Lu, Q. Li, and Z.-P. Li, “Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study,” Journal of Clinical Pharmacy and Therapeutics, 2018. View at Publisher · View at Google Scholar
  • Masashi Ohe, “Successful Treatment of Polymyalgia Rheumatica with Prednisolone in Combination with Clarithromycin and Tacrolimus,” Journal of Rheumatic Diseases, vol. 25, no. 1, pp. 73, 2018. View at Publisher · View at Google Scholar